Skip to main content

Xenon Pharmaceuticals Inc(XENE-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Xenon Pharmaceuticals Inc

200 - 3650 GILMORE WAY
BURNABY A1 V5G 4W8 CAN
P: 604-484-3300
F: 604-484-3450
http://www.xenon-pharma.com

Profile

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.

Key Executives

NameTitle
Ian C. MortimerCEO/Director/President
Sherry AulinCFO/Chief Accounting Officer

More from The Globe